It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Inflammatory bowel disease (IBD) is characterized by chronic, dysregulated inflammation in the gastrointestinal tract. The heterogeneity of IBD is reflected through two major subtypes, Crohn’s Disease (CD) and Ulcerative Colitis (UC). CD and UC differ across symptomatic presentation, histology, immune responses, and treatment. While colitis mouse models have been influential in deciphering IBD pathogenesis, no single model captures the full heterogeneity of clinical disease. The translational capacity of mouse models may be augmented by shifting to multi-mouse model studies that aggregate analysis across various well-controlled phenotypes. Here, we evaluate the value of histology in multi-mouse model characterizations by building upon a previous pipeline that detects histological disease classes in hematoxylin and eosin (H&E)-stained murine colons. Specifically, we map immune marker positivity across serially-sectioned slides to H&E histological classes across the dextran sodium sulfate (DSS) chemical induction model and the intestinal epithelium-specific, inducible Villin-CreERT2;Klf5fl/fl (Klf5ΔIND) genetic model. In this study, we construct the beginning frameworks to define H&E-patch-based immunophenotypes based on IHC-H&E mappings.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Brook University, Department of Biomedical Informatics, Renaissance School of Medicine at Stony, Stony Brook, USA (GRID:grid.36425.36) (ISNI:0000 0001 2216 9681)
2 Renaissance School of Medicine at Stony Brook University, Department of Medicine, Stony Brook, USA (GRID:grid.36425.36) (ISNI:0000 0001 2216 9681)
3 Brook University, Department of Biomedical Informatics, Renaissance School of Medicine at Stony, Stony Brook, USA (GRID:grid.36425.36) (ISNI:0000 0001 2216 9681); Renaissance School of Medicine at Stony Brook University, Department of Pathology, Stony Brook, USA (GRID:grid.36425.36) (ISNI:0000 0001 2216 9681)
4 Brook University, Department of Biomedical Informatics, Renaissance School of Medicine at Stony, Stony Brook, USA (GRID:grid.36425.36) (ISNI:0000 0001 2216 9681); Renaissance School of Medicine at Stony Brook University, Department of Medicine, Stony Brook, USA (GRID:grid.36425.36) (ISNI:0000 0001 2216 9681); Brook University, Department of Physiology and Biophysics, Renaissance School of Medicine at Stony, Stony Brook, USA (GRID:grid.36425.36) (ISNI:0000 0001 2216 9681)